We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TELO market cap is 187.43M. The company's latest EPS is USD -0.4415 and P/E is -14.41.
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | ||
| Operating Income | -1.08M | ||
| Net Income | -9.33M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -138k | -854k | -3.94M |
| Net Income | -138k | -854k | -13.07M |
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.77M | ||
| Total Liabilities | 1.34M | ||
| Total Equity | 3.44M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 49k | 4.77M |
| Total Liabilities | 138k | 986k | 1.34M |
| Total Equity | -138k | -937k | 3.44M |
| Market Cap | 187.43M |
| Price to Earnings Ratio | -14.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 54.78 |
| Dividend Yield | - |
| Shares Outstanding | 29.61M |
| Average Volume (1 week) | 18.48k |
| Average Volume (1 Month) | 22.14k |
| 52 Week Change | -9.57% |
| 52 Week High | 20.72 |
| 52 Week Low | 4.76 |
| Spread (Intraday) | 11.34 (67.62%) |
| Company Name | Telomir Pharmaceuticals Inc |
| Address |
900 west platt street, suite 200 tampa, florida 33606 |
| Website | https://www.telomirpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
